Institut Jules Bordet - Oncologie Médicale
Brussels, Brussels Capital Region, Belgium
Hospital in Anderlecht
Rue Meylemeersch 90, 1070 Bruxelles
About Institut Jules Bordet - Oncologie Médicale
Institut Jules Bordet is a specialized general hospital and research institute of the Université libre de Bruxelles which specializes in oncology. It is located in Brussels, Belgium.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
BeiGene
1
Clavis Pharma
1
Epizyme, Inc.
1
Merck KGaA, Darmstadt, Germany
1
SOTIO a.s.
1
Stemline Therapeutics, Inc.
1
Clinical Trials at Institut Jules Bordet - Oncologie Médicale
During the past decade, Institut Jules Bordet - Oncologie Médicale conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of CP-4126 in Patients With Advanced Pancreatic Cancer
2009-04-01
2011-09-01
Completed
21
A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer
2008-10-01
2011-03-01
Completed
26
Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
2014-05-26
2020-01-28
Completed
1,182
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
2015-12-22
2024-12-01
Active, not recruiting
250
Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer
2019-05-10
2024-08-01
Active, not recruiting
466
A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
2018-12-11
2023-09-30
Active, not recruiting
649
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Institut Jules Bordet - Oncologie Médicale" #1 sponsor was "BeiGene" with 1 trials, followed by "Clavis Pharma" with 1 trials
sponsored, "Epizyme, Inc." with 1 trials sponsored, "Merck KGaA, Darmstadt, Germany" with 1 trials sponsored and "SOTIO a.s."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Institut Jules Bordet - Oncologie Médicale
According to Clinical.Site data, the most researched conditions in "Institut Jules Bordet - Oncologie Médicale" are
"Advanced Adenocarcinoma of Pancreas" (1 trials), "Any Solid Tumor With an EZH2 GOF Mutation" (1 trials), "Atypical Teratoid Rhabdoid Tumors (ATRT)" (1 trials), "Bone Metastases" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Institut Jules Bordet - Oncologie Médicale" in a lesser frequency.
Clinical Trials Intervention Types at Institut Jules Bordet - Oncologie Médicale
Most popular intervention types in "Institut Jules Bordet - Oncologie Médicale" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Capecitabine" (1 trials), "Cisplatin" (1 trials), "DCVAC/PCa" (1 trials) and "EMD 525797" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Institut Jules Bordet - Oncologie Médicale
The vast majority of trials in "Institut Jules Bordet - Oncologie Médicale" are
4 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Institut Jules Bordet - Oncologie Médicale
Currently, there are NaN active trials in "Institut Jules Bordet - Oncologie Médicale".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Institut Jules Bordet - Oncologie Médicale,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institut Jules Bordet - Oncologie Médicale, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".